Assyro AI

Orange Book product · Brand (NDA)

CYSTARAN

CYSTEAMINE HYDROCHLORIDE

Brand (NDA)NDA 200740RX LEADIANT BIOSCI INC

At a glance

Oct 02, 2012

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 02, 2012

    13 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CYSTEAMINE HYDROCHLORIDE

Strength

EQ 0.44% BASE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 200740

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.